QUOTED. Martha Shadan.
Medtech Insight spoke what Martha Shadan, CEO of Miach Orthopaedics, about the company’s marketing efforts for its FDA-cleared BEAR implant for treating anterior cruciate ligament (ACL) tears. See what Shadan said about it here.
“We are the first to clinically demonstrate that we can restore the patient's own ACL rather than replacing it. All the other technologies, even some that are emerging, they still rely on replacing the ACL, and we're the only one that restores the ACL for the broad majority of tear indications.” – Martha Shadan, CEO, Miach Orthopedics
Click here for a free trial of Medtech Insight